Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma - Jackson, Daniel J. (University of Wisconsin School of Medicine and Public Health) ; Bacharier, Leonard B. (Monroe Carell Jr Children's Hospital at Vanderbilt University Medical Center, Nashville, Tennessee) ; Phipatanakul, Wanda (Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts) ; Sher, Lawrence (Peninsula Research Associates, Rolling Hills Estates, California.) ; Domingo, Christian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Papadopoulos, Nikolaos (University of Athens, Greece) ; Modena, Brian (Modena Allergy & Asthma, La Jolla, California) ; Li, Ning (Department of Immunology, Sanofi, Beijing, People's Republic of China) ; Xia, Changming (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Kamal, Mohamed A. (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Dillon, Myles (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Wolfe, Kelley (Department of Immunology, Sanofi, Bridgewater, New Jersey) ; Gall, Rebecca (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Amin, Nikhil (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Mannent, Leda P. (Department of Immunology, Sanofi, Chilly-Mazarin, France) ; Laws, Elizabeth (Sanofi (Bridgewater, New Jersey)) ; Rowe, Paul J. (Sanofi (Bridgewater, New Jersey)) ; Jacob-Nara, Juby A. (Sanofi (Bridgewater, New Jersey)) ; Deniz, Yamo (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Lederer, David J. (Regeneron Pharmaceuticals (Tarrytown, New York)) ; Hardin, Megan (Sanofi (Cambridge, Estats Units d'Amèrica)) ; Xu, Christine (Sanofi (Bridgewater, New Jersey)) ; Universitat Autònoma de Barcelona. Departament de Medicina